SAN JOSE, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) --
Intermolecular, Inc. today announced that GLOBALFOUNDRIES and
IBM will leverage Intermolecular's High Productivity
Combinatorial (HPC™) technology, as the companies work to
speed development of manufacturing technologies down to the
Intermolecular's combinatorial technology allows many
more tests to be done using a single wafer. This enables
experimental data to be generated and analyzed with
significantly greater speed and efficiency than a traditional
development line, accelerating innovation in materials,
processes, and device architectures.
"IBM and GLOBALFOUNDRIES are committed to pushing
forward the leading-edge of IC logic manufacturing with new
materials and device structures," said Gary Patton, VP
Semiconductor Research for IBM. "Intermolecular's
HPC technology will help to more rapidly explore materials
and processing options for advanced logic
"We are pleased that IBM and GLOBALFOUNDRIES will be
able to leverage our HPC platform to address
GLOBALFOUNDRIES' high-volume manufacturing R&D
challenges," said David Lazovsky, Intermolecular
president and CEO.
"Our business model is built on collaboration, both in
customer engagements and technology development,"
commented David Bennett, vice president of alliances for
GLOBALFOUNDRIES. "Collaborating with Intermolecular has
strengthened our R&D pipeline and improved R&D
Intermolecular's mission is to drive our customers'
success by transforming R&D and accelerating innovation in
markets that derive competitive advantage from the
interaction of materials science, processes, integration and
Statements made in this press release that are not statements
of historical fact are forward-looking statements.
Forward-looking statements are subject to the "safe
harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements in this press
release relate, but are not limited, to the Company's
expectations for any incremental revenue related to the
technology that is being leveraged. Forward-looking
statements are subject to risks and uncertainties that could
cause actual results to differ materially from expectations,
including but not limited to risks detailed from time to time
under the heading "Risk Factors" in the
Company's report on Form 10-K for fiscal year 2011, and
its subsequent reports on Form 10-Q for fiscal year 2012. The
Company disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
About Intermolecular, Inc.
Intermolecular® has pioneered a proprietary approach to
accelerate research and development, innovation, and
time-to-market for the semiconductor and clean energy
industries. The approach consists of its proprietary HPCTM
platform, coupled with its multi-disciplinary team. Through
paid collaborative development programs (CDPs) with its
customers, Intermolecular develops proprietary technology and
intellectual property for its customers focused on advanced
materials, processes, integration and device architectures.
Founded in 2004, Intermolecular is based in San Jose,
California. "Intermolecular" and the Intermolecular
logo are registered trademarks; and "HPC" is a
trademark of Intermolecular, Inc.; all rights reserved. Learn
more at www.intermolecular.com.
CONTACT: Press Contact
Ed Korczynski, Intermolecular
Marketing Communications Director
Investor Relations Contact
Gary Hsueh, Intermolecular
Sr. Director of Corporate Development and Investor Relations